Atopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Atopic Dermatitis Clinical Trials Analysis Report Overview
The atopic dermatitis clinical trial market research report provides an overview of the Atopic Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic dermatitis. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).
Key Regions | · Asia-Pacific
· Europe · North America · Middle East & Africa · South & Central America |
Key Countries | · The United States
· Germany · China · Japan · Others |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · Pfizer Inc
· Novartis AG · Sanofi · LEO Foundation · Others |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Atopic dermatitis Clinical Trials Market Segmentation by Regions and Countries
The key regions in the atopic dermatitis clinical trials market are Asia-Pacific, Europe, North America, the Middle East & Africa, and South & Central America. The Asia-Pacific region dominated the market as of September 2023 and was followed by North America and Europe.
In a country-wise analysis, as of September 2023, the US had the highest number of atopic dermatitis clinical trials, followed by Germany, China, Japan, and Canada, among others.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada and Japan) countries, Canada had the highest proportion of Atopic dermatitis to Dermatology clinical trials as of September 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey and Indonesia) countries, Mexico had the highest proportion of Atopic dermatitis to Dermatology clinical trials as of September 2023.
Atopic Dermatitis Clinical Trials Analysis by Regions, 2023 (%)
Buy The Full Report For More Regional Insights Into The Atopic Dermatitis Clinical Trials Market, Download A Free Report Sample
Atopic Dermatitis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Atopic Dermatitis clinical trials market are institution, company, and the government. Out of them, the company sponsor type dominated the market, followed by institution in 2023
Atopic dermatitis Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
Buy the Full Report For More Sponsor Type Insights Into The Atopic Dermatitis Clinical Trials Market, Download A Free Report Sample
Atopic Dermatitis Clinical Trials Market - Competitive Landscape
The leading sponsors in the atopic dermatitis clinical trials market are Pfizer Inc, Novartis AG, Sanofi, and LEO Foundation among others. Pfizer Inc led the atopic dermatitis clinical trials market in September 2023.
Atopic Dermatitis Clinical Trials Market Analysis by Sponsors, 2023 (%)
Buy the Full Report To Know More About The Leading Players In The Atopic Dermatitis Clinical Trials Market, Download A Free Report Sample
Segments Covered in the Report
Atopic Dermatitis Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Atopic Dermatitis Clinical Trials Country Outlook (2023)
- The United States
- Japan
- China
- United Kingdom
- Canada
- Germany
- Australia
- Spain
- France
- Netherlands
Atopic Dermatitis Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status.
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment.
- The Report provides enrollment trends for the past five years.
- Report provides latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Novartis AG
Sanofi
LEO Foundation
Regeneron Pharmaceuticals Inc
Eli Lilly and Co
GSK plc
Johnson & Johnson
Innovaderm Research Inc
AbbVie Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which is the leading region in the atopic dermatitis clinical trials market?
Asia-Pacific is the leading region in the atopic dermatitis clinical trials market as of September 2023.
-
Which is the leading country in the atopic dermatitis clinical trials market?
The US is the leading country in the atopic dermatitis clinical trials market as of September 2023.
-
Which is the leading sponsor types in the atopic dermatitis clinical trials market?
Company is the leading sponsor type in the atopic dermatitis clinical trials market as of September 2023.
-
Who are the leading sponsors in the atopic dermatitis clinical trials market?
The leading sponsors in the atopic dermatitis clinical trials market are Pfizer Inc, Novartis AG, Sanofi, and LEO Foundation among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.